Results 131 to 137 of about 1,352 (137)

The Evaluation of (1<i>R</i>,4<i>R</i>,7<i>R</i>,10<i>R</i>)-α,α',α″,α‴-Tetramethyl-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic Acid (DOTMA) as a Chelator for Zirconium-89. [PDF]

Molecules
Pandya DN, Miro P, Sinnwell MA, Crull GB, Wadas TJ.   +4 more
europepmc   +1 more source

MIB guides: [⁸⁹Zr]Zr-DFO-trastuzumab and [⁶⁴Cu]Cu-NOTA-Trastuzumab for Preclinical Cancer Imaging. [PDF]

Mol Imaging Biol
Simó C, Vanover AC, Azevedo EC, Pereira PMR.   +3 more
europepmc   +1 more source

⁸⁹Zr-Radiolabelling of p-NCS-Bz-DFO-Anti-HER2 Affibody Immunoconjugate: Characterization and Assessment of In Vitro Potential in HER2-Positive Breast Cancer Imaging. [PDF]

Pharmaceutics
Tudoroiu-Cornoiu MR, Șerban RM, Cocioabă D, Niculae DA, Drăgănescu D, Leonte R, Ion AC, Niculae D.   +7 more
europepmc   +1 more source

LAMP1 as a Target for PET Imaging in Adenocarcinoma Xenograft Models. [PDF]

Pharmaceuticals (Basel)
Ataeinia B, Haj-Mirzaian A, Ben-Naim L, Esfahani SA, Marcos Vidal A, Mahmood U, Heidari P.   +6 more
europepmc   +1 more source

Targeting Glypican-3 in Liver Cancer: Groundbreaking Preclinical and Clinical Insights. [PDF]

Biomedicines
Filippi L, Frantellizzi V, Urso L, De Vincentis G, Urbano N.   +4 more
europepmc   +1 more source

Delta-Like Ligand 3 Expression and Functional Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms. [PDF]

JCO Precis Oncol
Thummalapalli R, Tendler S, Chou JF, Tarcan ZC, Porfido C, Willner J, Linkov I, Bhanot U, Cooper AJ, Xu J, Harding JJ, Rekhtman N, Tang LH, Rudin CM, Janjigian YY, Schöder H, Porier JT, Shia J, Basturk O, Reidy-Lagunes D, Capanu M, Lewis JS, Bodei L, Dunphy MP, Raj N.   +24 more
europepmc   +1 more source

ImmunoPET with Zirconium-89 specifically detects postoperative biofilm-associated implant infections. A preclinical study.

Nurmohamed FRHA, Allen KJ, Frank C, Malo ME, Duyvenbode JFFHv, Wildt Bvd, Poot AJ, Lam MGEH, Strijp JAGv, Vogely HC, Weinans H, Dadachova E, Wal BCHvd.   +12 more
europepmc   +1 more source